DrKC leads new investors in Inpharmatica
The drug discovery company has raised £31.25m in a second round private placement managed by CSFB.
The drug discovery company has raised £31.25m in a second round private placement managed by CSFB.
Copyright PEI Media
Not for publication, email or dissemination